CCR Creative Clinical Research GmbH Privates Institut fuer Kreative Klinische Forschung
CCR Creative Clinical Research GmbH Privates Institut fuer Kreative Klinische Forschung is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A prospective, multicenter, open-label, randomized, actively controlled, parallel-group Phase 3 clinical trial to evaluate efficacy, safety, and tolerability of IMA203 versus investigator’s choice of treatment in patients with previously treated, unresectable or metastatic cutaneous melanoma (ACTengine® IMA203-301)
Sponsor Immatics US Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase I/II First-In-Human Clinical Trial to Evaluate the Safety, Tolerability and Anti-Tumor Activity of IMA402, a Bispecific T Cell-Engaging Receptor Molecule (TCER®) targeting PRAME, as Monotherapy or in Combination with a Checkpoint Inhibitor in Patients with Recurrent and/or Refractory Solid Tumors
Sponsor Immatics Biotechnologies GmbH
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for CCR Creative Clinical Research GmbH Privates Institut fuer Kreative Klinische Forschung?
The 2026-10-09 snapshot links CCR Creative Clinical Research GmbH Privates Institut fuer Kreative Klinische Forschung to 2 distinct CTIS trials. Recorded services include Medical expertise. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for CCR Creative Clinical Research GmbH Privates Institut fuer Kreative Klinische Forschung?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to CCR Creative Clinical Research GmbH Privates Institut fuer Kreative Klinische Forschung conducted?
The linked trials record locations in 3 countries, including Germany, Netherlands, France. These are trial locations, not confirmed office locations or countries where CCR Creative Clinical Research GmbH Privates Institut fuer Kreative Klinische Forschung delivered services.
What can this page tell me about CCR Creative Clinical Research GmbH Privates Institut fuer Kreative Klinische Forschung's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under CCR Creative Clinical Research GmbH Privates Institut fuer Kreative Klinische Forschung. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- CCR Creative Clinical Research GmbH Privates Institut fuer Kreative Klinische Forschung